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4a Saturday, February 15, 2014Ca2þ dysregulation followed by rapid loss of IMM potential known as perme-
ability transition (PT), which produces osmotic shifts, metabolic dysfunction
and cell death. The molecular identity of the mitochondrial PT pore (mPTP)
is still in question. We had described previously that, through protein-protein
interaction with the beta subunit of the ATP synthase, the anti-apoptotic protein
Bcl-xL decreased an inner membrane leak conductance to increase bioener-
getic efficiency during neuronal activity. To identify the source of the leak,
we used patch clamp recording of submitochondrial vesicles. We have now
shown that the leak channel most likely regulated by interaction with the
beta subunit is the c-subunit ring of the F1FO ATP synthase and we further sug-
gest that this channel forms the mPTP. High Ca2þ enlarges the c-subunit ring
and uncouples it from Ca2þ/ cyclosporine A (CsA) binding sites in the F1 of the
ATP synthase. Depletion of the c-subunit prevents PT and attenuates cell death,
while increasing the expression or conductance of the c-subunit channel sensi-
tizes cells to death. Physical uncoupling of F1 from FO occurs when PT is
induced, and an antibody specific to the c-subunit inhibits c-subunit channel
conductance and prevents calcium-induced IMM channel activity. We
conclude that a highly regulated c-subunit leak channel is the mPTP.
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Mitochondrial potassium channels play an important role in cytoprotection.
The following potassium channels have been described in the inner mitochon-
drial membrane: the ATP-regulated potassium channel, the large conductance
calcium activated potassium channel, the voltage-gated potassium channel and
the twin-pore domain TASK-3 potassium channel. Potassium channels in the
inner mitochondrial membrane are modulated by inhibitors and activators (po-
tassium channel openers) previously described for plasma membrane potas-
sium channels. The majority of mitochondrial potassium channel modulators
exhibit a broad spectrum of off-target effects. These include uncoupling prop-
erties, inhibition of the respiratory chain and effects on cellular calcium homeo-
stasis. Therefore, the rational application of channel inhibitors or activators is
crucial to understanding the cellular consequences of mitochondrial channel in-
hibition or activation. In this paper, new observations on mitochondrial potas-
sium channel will be discussed: 1). their molecular identity, 2). their interaction
with potassium channel openers and inhibitors and 3). their functional role.
22-Subg
Inhibition of a Mitochondrial Potassium Channel as a New Therapeutic
Strategy for Chronic Lymphocytic Leukemia
Ildiko` Szabo`, Ph.D1, Luigi Leanza2, Antonella Manago`2, Federica Frezzato2,
Kathrin Becker3, Livio Trentin2, Gianpietro Semenzato2, Erich Gulbins3,
Mario Zoratti2.
1Department of Biology, University of Padova, Padova, Italy, 2University of
Padova, Padova, Italy, 3University of Duisburg-Essen, Essen, Germany.
Ion channels are involved in the regulation of proliferation and apoptosis and
are emerging as promising oncological targets. We have recently identified
three membrane-permeant inhibitors of the Kv1.3 potassium channel as in-
ducers of apoptosis. These inhibitors induce mitochondrial membrane potential
changes, increase of ROS release and opening of the permeability transition
pore finally leading to cytochrome c release and cells death. Death occurs
only when Kv1.3 is active in the inner mitochondrial membrane (mtKv1.3)
and also in the absence of Bax and Bak. Efficiency of one of these inhibitors
to reduce tumor volume in vivo was demonstrated in a melanoma orthotopic
mouse model (Leanza, et al., 2012 EMBO Molecular Medicine). The same
signaling pathway and a selective action of the Kv1.3 inhibitors was observed
in B lymphocytes of patients suffering of Chronic lymphocytic leukemia (B-
CLL) (Leanza, et al., 2013 Leukemia). Regarding the mechanism of selectivity,
we defined that synergy between the level of Kv1.3 expression and an altered
redox state in B-CLL cells determines the susceptibility of these cells. Since
Kv1.3 inhibitors kill B-CLL by direct interference with mitochondrial func-
tions, they act on these malignant cells independent of classic prognostic fac-
tors and Bcl-2 overexpression. To generalize our findings, in addition to
melanoma and B-CLL cells, the effect of these inhibitors on cell survival
was measured on different cancer cell lines expressing Kv1.3. A correlation be-
tween Kv1.3 expression and susceptibility to mtKv1.3 inhibitors was found.23-Subg
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Proteins are decorated with a suite of chemical modifications, which regulate
their activity and overall metabolic homeostasis. The most well-studied
lysine modification is acetylation, and hyperacetylation of several proteins
leads to metabolic dysfunction and potentially contributes to human disease.
More recently, new chemical modifications that regulate protein activity
have emerged, including succinylation and malonylation, however little is
known about the biology regulated by these modifications. The suite of
acyl-based chemical modifications of mitochondrial proteins is regulated
by a family of NADþ-dependent deacetylase enzymes call the sirtuins
(SIRT1-7), which have also been termed ‘‘deacylases’’ for their new enzy-
matic activities. We recently discovered new protein modifications present
on cellular proteins, which provides important insight into the regulatory
role of the sirtuins.
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Mitochondria are complex and dynamic organelles that are essential to the sur-
vival of nearly every eukaryotic cell. To generate a foundation for systematic
investigations of mitochondrial function and adaptation, we recently estab-
lished a protein compendium of these organelles across a wide range of tissues
from healthy mice. This resource, termed MitoCarta, provides a robust, yet
static view of the mitochondrial proteome. We are now applying MitoCarta
as a framework for quantifying how mitochondrial proteins and post-
translational modifications (PTMs, e.g., phsophorylation and acetylation)
change during acute and chronic metabolic perturbations, and to elucidate
the role of these changes in regulating mitochondrial activity. To do so, we
blend state-of-the art multi-plexed mass spectrometry-based proteomics with
focused biochemistry and molecular biology approaches.
In particular, we have recently taken this approach to capture the mitochondrial
proteome dynamics during fasting, the onset of obesity, aging, caloric restric-
tion and acute iron deprivation. Our analyses have revealed hundreds of
dynamic phosphorylation and acetylation events and have produced quantita-
tive, searchable maps of mitochondrial alterations across a spectrum of meta-
bolic states. We have leveraged these data to demonstrate that key steps in
ketogenesis, the TCA cycle, branched-chain amino acid degradation and fatty
acid oxidation are regulated by reversible PTMs, and that the mitochondrial
oxidative phosphorylation machinery is highly calibrated to cellular iron con-
tent. Moving forward, we plan to further elucidate the mitochondrial signaling
network by identifying the regulatory enzymes (e.g., kinases, acetyltrans-
ferases, etc.) responsible for managing mitochondrial PTMs, and to define
the functions of uncharacterized mitochondrial proteins mutated in human
disease.
Subgroup: Intrinsically Disordered Proteins
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One particularly useful approach for investigating protein folding is ‘The
Fold Approach’, which involves a detailed analysis of the folding of several
topologically, structurally and/or evolutionarily related proteins in order to
discern patterns and trends in folding (stability, pathways and mechanisms).
We are now applying this approach to the folding of intrinsically disordered
proteins.
The three systems we are studying all involve formation of helical structure
when a disordered protein binds its target. The properties of these systems
are vastly different, from mM - nM binding affinity and with association and
disassociation rate constants varying by many orders of magnitude. This brings
different challenges for determining the kinetics of assembly and disassembly.
We can use protein engineering approaches, pioneered in protein folding
studies to investigate the mechanism of binding, ask whether the presence of
residual structure in the disordered peptide affects binding, and investigate
the importance of solvent.
Our results challenge some of the long held views on IDPs - how important re-
sidual structure is to binding; the idea that IDPs are special in conferring high
specificity combined with low affinity. Can we relate biophysical properties to
specific IDP functions?
